 | What Percentage Of Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Do Insiders Own?
finance.yahoo.com - July 17 at 3:43 PM |
| Aquestive Therapeutics Completes $70 Million Debt Refinancing
finance.yahoo.com - July 16 at 11:33 AM |
 | Aquestive Therapeutics Inc (NASDAQ:AQST) Short Interest Update
www.americanbankingnews.com - July 11 at 6:33 PM |
| Wedbush Analysts Give Aquestive Therapeutics (NASDAQ:AQST) a $31.00 Price Target
www.americanbankingnews.com - July 8 at 4:00 PM |
| Aquestive Therapeutics Inc (NASDAQ:AQST) Expected to Announce Quarterly Sales of $10.45 Million
www.americanbankingnews.com - June 30 at 3:26 AM |
| -$0.67 Earnings Per Share Expected for Aquestive Therapeutics Inc (NASDAQ:AQST) This Quarter
www.americanbankingnews.com - June 28 at 10:12 AM |
| Aquestive Therapeutics Inc (NASDAQ:AQST) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 27 at 4:29 AM |
 | Heron Could Be The Next Home Run In Combating The Opiodemic
seekingalpha.com - June 18 at 2:20 PM |
| Aquestive Therapeutics Completes Enrollment in Libervant™ (diazepam buccal film) Crossover Study
finance.yahoo.com - June 4 at 12:02 PM |
| Aquestive Therapeutics to Present at Two Upcoming Investor Conferences
finance.yahoo.com - May 13 at 12:02 PM |
| New operating chief at Aquestive
seekingalpha.com - May 8 at 12:09 PM |
| Aquestive Therapeutics: 1Q Earnings Snapshot
finance.yahoo.com - May 8 at 12:08 PM |
| Need To Know: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Insiders Have Been Buying Shares
finance.yahoo.com - April 27 at 11:36 AM |
| Aquestive Therapeutics to Announce First Quarter 2019 Financial Results and Recent Business Highlights on May 8, 2019
finance.yahoo.com - April 18 at 12:34 PM |
| FDA accepts Aquestive's application for riluzole oral film for ALS
seekingalpha.com - April 16 at 1:38 PM |
| Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application for Riluzole Oral Film for Treatment of ALS
finance.yahoo.com - April 16 at 1:38 PM |
| Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 26 at 12:28 PM |
| Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why
finance.yahoo.com - March 21 at 11:10 AM |
| Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why
finance.yahoo.com - March 21 at 11:10 AM |
 | Aquestive Therapeutics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 3:57 PM |
| Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights
finance.yahoo.com - March 14 at 12:31 PM |
| Aquestive Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 14 at 12:31 PM |
| Aquestive Therapeutics to Present at Oppenheimer's 29th Annual Healthcare Conference
finance.yahoo.com - March 7 at 3:48 PM |
| Aquestive Therapeutics: Specialty Pharma Company With Multiple Value Drivers
seekingalpha.com - March 1 at 12:26 PM |
| Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights on March 14, 2019
finance.yahoo.com - February 19 at 11:43 AM |
| Aquestive Therapeutics to Present at 2019 BIO CEO & Investor Conference
finance.yahoo.com - February 8 at 11:39 AM |
| Aquestive Therapeutics Provides Update Regarding Suboxone® Sublingual Film Litigation
finance.yahoo.com - February 5 at 10:38 AM |
| Aquestive down 29% premarket on Sunovion CRL for Parkinson's candidate
seekingalpha.com - January 31 at 11:27 AM |
| Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.'s Apomorphine Sublingual Film (APL-130277) New Drug Application
finance.yahoo.com - January 31 at 11:27 AM |
| Aquestive Therapeutics Granted Temporary Restraining Order (TRO) Against Alvogen
finance.yahoo.com - January 25 at 3:37 PM |
 | Aquestive Therapeutics Inc.
www.barrons.com - January 4 at 3:29 PM |
| Aquestive Therapeutics Appoints Gary H. Slatko, M.D. as Chief Medical Officer
finance.yahoo.com - January 4 at 9:34 AM |
| Needham sees 27% upside in Thermo Fisher in today's analyst action
seekingalpha.com - January 3 at 3:31 PM |
| Aquestive Therapeutics, Inc.’s (NASDAQ:AQST) Shift From Loss To Profit
finance.yahoo.com - December 21 at 3:27 PM |
| Aquestive Therapeutics provides year end business update
seekingalpha.com - December 20 at 9:45 AM |
 | Aquestive Therapeutics Schedules Business Update...
www.benzinga.com - December 19 at 9:39 AM |
| Aquestive Therapeutics schedules business update conference call on December 20
seekingalpha.com - December 19 at 9:39 AM |
| Aquestive Therapeutics Schedules Business Update Conference Call on December 20, 2018
finance.yahoo.com - December 19 at 9:39 AM |
| Aquestive Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
finance.yahoo.com - December 7 at 8:43 AM |
 | Aquestive Therapeutics (AQST) nnounces Late-Breaking Findings of its Investigational DBF Formulation in Adults with Epilepsy
www.streetinsider.com - December 3 at 3:22 PM |
| Aquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with Epilepsy
finance.yahoo.com - December 3 at 3:22 PM |
| Aquestive continues post-CRL selloff, shares down 6%
seekingalpha.com - November 30 at 3:23 PM |
| Aquestive launches Sympazan in U.S.
seekingalpha.com - November 29 at 3:23 PM |
| Aquestive Therapeutics (AQST) Launches SYMPAZAN Oral Film
www.streetinsider.com - November 29 at 3:23 PM |
| Aquestive Therapeutics Launches SYMPAZAN™ (clobazam) Oral Film with Widespread U.S. Availability
finance.yahoo.com - November 29 at 3:23 PM |
| The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates
finance.yahoo.com - November 19 at 8:02 AM |
| Aquestive Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration (FDA) for Tadalafil Oral Film
finance.yahoo.com - November 17 at 8:12 AM |
| Aquestive Therapeutics (AQST) CEO Keith Kendall on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 3:24 PM |
 | New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved
247wallst.com - November 8 at 3:24 PM |
| Aquestive Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights
finance.yahoo.com - November 7 at 7:49 AM |
